Apolipoprotein A-IV is involved in detection of lipid in the rat intestine

Journal of Physiology

Volumn 569, Issue 3, 2005, Pages 949-958

  Whited, K L ^a   Lu, D ^a   Tso, P ^b   Lloyd, K C Kent ^a   Raybould, H E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A4; LIPID; PROTEIN FOS; CHOLECYSTOKININ; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; FAT INTAKE; FEEDING; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; MALE; MEAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SOLITARY TRACT NUCLEUS; STOMACH ACID SECRETION; STOMACH EMPTYING; STOMACH FUNCTION; STOMACH SCINTISCANNING; VAGUS NERVE; WAKEFULNESS; BREGMA; EGG; FOOD INTAKE; INTESTINE; LIPID DIET; NERVE CELL STIMULATION; SENSORY NERVE; TRIACYLGLYCEROL BLOOD LEVEL; VAGUS NERVE STIMULATION;

ANIMALS; APOLIPOPROTEINS A; CHOLECYSTOKININ; DEVAZEPIDE; GASTRIC ACID; GASTRIC EMPTYING; HORMONE ANTAGONISTS; INTESTINES; INTUBATION, GASTROINTESTINAL; LIPIDS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; PROTO-ONCOGENE PROTEINS C-FOS; SOLITARY NUCLEUS; TRIGLYCERIDES; VAGUS NERVE;

EID: 29244471304     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2005.097634     Document Type: Article

References (44)

1. Apfelbaum TF, Davidson NO & Glickman RM (1987). Apolipoprotein A-IV synthesis in rat intestine: regulation by dietary triglyceride. Am J Physiol 252, G662-G666.
2. Baroukh N, Ostos MA, Vergnes L, Recalde D, Staels B, Fruchart J, Ochoa A, Castro G & Zakin MM (2001). Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice reduces atherogenesis in response to a high fat-high cholesterol diet. FEBS Lett 502, 16-20.
3. Berthoud HR, Kressel M, Raybould HE & Neuhuber WL (1995). Vagal sensors in the rat duodenal mucosa: distribution and structure as revealed by in vivo DiI-tracing. Anat Embryol 191, 203-212.
4. Berthoud HR & Neuhuber WL (2000). Functional and chemical anatomy of the afferent vagal system. Auton Neurosci 85, 1-17.
5. Cohen RD, Castellani LW, Qiao JH, Van Lenten BJ, Lusis AJ & Reue K (1997). Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV. J Clin Invest 99, 1906-1916.
6. Duverger N, Tremp G, Caillaud JM, Emmanuel F, Castro G, Fruchart JC, Steinmetz A & Denefle P (1996). Protection against atherogenesis in mice mediated by human apolipoprotein A-IV. Science 273, 966-968.
7. Elmquist JK, Elias CF & Saper CB (1999). From lesions to leptin: hypothalamic control of food intake and body weight. Neuron 22, 221-232.
8. Elshourbagy NA, Walker DW, Paik YK, Boguski MS, Freeman M, Gordon JI & Taylor JM (1987). Structure and expression of the human apolipoprotein A-IV gene. J Biol Chem 262, 7973-7981.
9. Fujimoto K, Cardelli JA & Tso P (1992). Increased apolipoprotein A-IV in rat mesenteric lymph after lipid meal acts as a physiological signal for satiation. Am J Physiol 262, G1002-G1006.
10. Fujimoto K, Fukagawa K, Sakata T & Tso P (1993). Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats. J Clin Invest 91, 1830-1833.
11. Glatzle J, Darcel N, Rechs AJ, Kalogeris TJ, Tso P & Raybould HE (2004). Apolipoprotein A-IV stimulates duodenal vagal afferent activity to inhibit gastric motility via a CCK1 pathway. Am J Physiol Regul Integr Comp Physiol 287, R354-R359.
12. Glatzle J, Kalogeris TJ, Zittel TT, Guerrini S, Tso P & Raybould HE (2002). Chylomicron components mediate intestinal lipid-induced inhibition of gastric motor function. Am J Physiol Gastrointest Liver Physiol 282, G86-G91.
13. Glatzle J, Wang Y, Adelson DW, Kalogeris TJ, Zittel TT, Tso P, Wei JY & Raybould HE (2003). Chylomicron components activate duodenal vagal afferents via a cholecystokinin A receptor-mediated pathway to inhibit gastric motor function in the rat. J Physiol 550, 657-664.
14. Hayashi H, Fujimoto K, Cardelli JA, Nutting DF, Bergstedt S & Tso P (1990). Fat feeding increases size, but not number, of chylomicrons produced by small intestine. Am J Physiol 259, G709-G719.
15. Hölzer HH, Turkelson CM, Solomon TE & Raybould HE (1994). Intestinal lipid inhibits gastric emptying via CCK and a vagal capsaicin-sensitive afferent pathway in rats. Am J Physiol 267, G625-G629.
16. Hunt JN & Knox MT (1968). A relation between the chain length of fatty acids and the slowing of gastric emptying. J Physiol 194, 327-336.
17. Isaacs PE, Ladas S, Forgacs IC, Dowling RH, Ellam SV, Adrian TE & Bloom SR (1987). Comparison of effects of ingested medium- and long-chain triglyceride on gallbladder volume and release of cholecystokinin and other gut peptides. Dig Dis Sci 32, 481-486.
18. Lal S, Kirkup AJ, Brunsden AM, Thompson DG & Grundy D (2001). Vagal afferent responses to fatty acids of different chain length in the rat. Am J Physiol 281, G907-G915.
19. Lichtenstein AH, Kennedy E, Barrier P, Danford D, Ernst ND, Grundy SM, Leveille GA, Van Horn L, Williams CL & Booth SL (1998). Dietary fat consumption and health. Nutr Rev 56, S3-S19.
20. Liddle RA (1994). Regulation of cholecystokinin synthesis and secretion in rat intestine. J Nutr 124,1308S-1314S.
21. Liu M, Doi T, Shen L, Woods SC, Seeley RJ, Zheng S, Jackman A & Tso P (2001). Intestinal satiety protein apolipoprotein AIV is synthesized and regulated in rat hypothalamus. Am J Physiol Regul Integr Comp Physiol 280, R1382-RI387.
22. Lloyd KCK, Raybould HE & Walsh JA (1992). Cholecystokinin inhibits gastric acid secretion through type "A" cholecystokinin receptors and somatostatin in rats. Am J Physiol 263, G287-G292.
23. Mantella RC, Rinaman L, Vollmer RR & Amico JA (2003). Cholecystokinin and D-fenfluramide inhibit food intake in oxytocin-deficient rats. Am J Physiol 285, 1037-1045.
24. Matzinger D, Degen L, Drewe J, Meuli J, Duebendorfer R, Ruckstuhl N, D'Amato M, Rovati L & Beglinger C (2000). The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans. Gut 46, 688-693.
25. 2+ -dependent mechanism in the enteroendocrine cell line STC-1. J Physiol 513, 11-18.
26. Moragas G, Azpiroz F, Pavia J & Malagelada J (1993). Relations among intragastric pressure, postcibal perception, and gastric emptying. Am J Physiol 264, G1112-G1117.
27. Moran TH & Kinzig KP (2004). Gastrointestinal satiety signals II. Cholecystokinin. Am J Physiol Gastrointest Liver Physiol 286, G183-G188.
28. Okumura T, Fukagawa K, Tso P, Taylor IL & Pappas TN (1994). Intracisternal injection of apolipoprotein A-IV inhibits gastric secretion in pylorus-ligated conscious rats. Gastroenterology 107, 1861-1864.
29. Okumura T, Fukagawa K, Tso P, Taylor IL & Pappas TN (1995). Mechanism of action of intracisternal apolipoprotein A-IV in inhibiting gastric acid secretion in rats. Gastroenterology 109, 1583-1588.
30. Okumura T, Fukagawa K, Tso P, Taylor IL & Pappas TN (1996). Apolipoprotein A-IV acts in the brain to inhibit gastric emptying in the rat. Am J Physiol 270, G49-G53.
31. Paxinos G & Franklin K (2001). The Mouse Brain in Sterotaxic Coordinates, 2nd edn. Academic Press, San Diego.
32. Qin X, Swertfeger DK, Zheng S, Hui DY & Tso P (1998). Apolipoprotein AIV. a potent endogenous inhibitor of lipid oxidation. Am J Physiol 274, H1836-H1840.
33. Raybould HE (2002). Visceral perception: sensory transduction in visceral afferents and nutrients. Gut 51 (Suppl. 1), i11-i14.
34. Rodriguez MD, Kalogeris TJ, Wang XL, Wolf R & Tso P (1997). Rapid synthesis and secretion of intestinal apolipoprotein A-IV after gastric fat loading in rats. Am J Physiol 272, R1170-RI177.
35. Sagar SM, Sharp FR & Curran T (1988). Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 240, 1328-1331.
36. Shortt J (2004). Obesity - a public health dilemma. AORNJ 80, 1069-1078.
37. 2+ in two enteroendocrine cell lines, STC- 1 and GLUTag. J Physiol 528, 165-176.
38. Tso P, Liu M, Kalogeris TJ & Thomson AB (200 1). The role of apolipoprotein A-IV in the regulation of food intake. Annu Rev Nutr 21, 231-254.
39. Vergnes L, Baroukh N, Lehy T, Moizo L, Bado A, Baralle M, Baralle FE, Zakin MM & Ochoa A (1999). Human apolipoprotein A-IV reduces gastric acid secretion and diminishes ulcer formation in transgenic mice. FEBS Lett 460,178-181.
40. Weinstock PH, Bisgaier CL, Hayek T, Aalto-Setala K, Sehayek E, Wu L, Sheiffele P, Merkel M, Essenburg AD & Breslow JL (1997). Decreased HDL cholesterol levels but normal lipid absorption, growth, and feeding behavior in apolipoprotein A-IV knockout mice. J Lipid Res 38, 1782-1794.
41. Wenk C (2004). Implications of dietary fat for nutrition and energy balance. Physiol Behav 83, 565-571.
42. Whited KL, Hornof WJ, Garcia T, Bohan DC, Larson RF & Raybould HE (2004). A non-invasive method for measurement of gastric emptying in mice: effects of altering fat content and CCK A receptor blockade. Neurogastroenterol Motil 16,421-427.
43. Wu AL & Windmueller HG (1979). Relative contributions by liver and intestine to individual plasma apolipoproteins in the rat. J Biol Chem 254, 7316-7322.
44. Zittel TT, de Giorgio R, Sternini C & Raybould HE (1994). Fos protein expression in the nucleus of the solitary tract in response to intestinal nutrients in awake rats. Brain Res 663, 266-270.